By helping to reduce food intake and promote a feeling of fullness, Semaglutide supports weight management, which can be especially important for people with Type 2 diabetes, as excess weight often contributes to difficulties in managing blood sugar
Other recognized adverse effects include injection site reactions, fatigue, headache, and dizziness
They highlight the significance of tracking important metrics like dosage, side effects, protein intake, body composition, and heart rate variability using a dashboard tool, Heads Up, for improved results
A useful benchmark: if you have lost 20 percent or more of starting body weight, if your appetite is well-controlled, and if you are tolerating the current dose without significant GI burden, there is no clinical imperative to escalate further
Both compounds activate the GLP-1 and GIP receptors, so combining them produces receptor overstimulation rather than additive benefits
GLP-1 receptor agonists, like the active ingredient in Zepbound, improve the bodys sensitivity to insulin
